Sign inJoin waitlistJoin the waitlist

TO

Thomas Olencki

Medical Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Detroit Medical Center
1984–1985
Internal Medicine
Corewell Health William Beaumont University Hospital
1981–1984
Michigan State University College of Osteopathic Medicine
1976–1980

Research

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
New England Journal of Medicine · 2016 · 992 citations
Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial
Journal of Clinical Oncology · 2017 · 575 citations
Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma
PLoS ONE · 2014 · 414 citations

RB
Ronald Bukowski
33 papers
Thomas Budd
20 papers
KK
Kari Kendra
17 papers
William Carson
15 papers
David Peereboom
13 papers
Toni Choueiri
12 papers
Paul Nghiem
11 papers
MM
Marc Michaelson
10 papers
RM
Robert Motzer
10 papers
BR
Bruce Redman
9 papers
Eric Jonasch
9 papers
Neeraj Agarwal
9 papers